New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.
Two-part Nov. 1, 2019 meeting will highlight unmet needs and treatment expectations
Dravet Syndrome, a catastrophic form of epilepsy, affects one in 15,700 children and adults in the United States.
An unexpected brain region is important for Dravet Syndrome, finds study from the Gladstone Institutes
BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders
Dravet Syndrome is a catastrophic form of epilepsy, affecting one in 15,700 children and adults in the United States.
